A Patient with Type 2 Diabetes Mellitus and Obesity: Administration of Ipragliflozin in the Clinical Practice of the Endocrinologist and Therapist
Personalized complex therapy of diabetes mellitus is aimed at the prevention of chronic diabetic complications, including compliance with dietary recommendations, physical activity, adequate glycemic control with the achievement of individual target glucose levels, blood pressure control, etc. An effective and safe antidiabetic therapy that should be taking into account comorbidities, age and renal function, is crucial. For patients with type 2 diabetes mellitus and obesity, safe and well tolerated drugs that have cardio- and nephroprotective effects and effectively reduce body weight along with hypoglycemic effects are recommended. One of such drug agents is ipragliflozin. The paper presents a clinical case of the effective use of ipragliflozin in a patient with type 2 diabetes mellitus and obesity.